Evaluation of Efficacy of Serum Procalcitonin Measurements in the Clinical Management of Acute Cholangitis

Evaluation of Efficacy of Serum Procalcitonin Measurements in the Clinical Management of Acute Cholangitis - Efficacy of Procalcitonin in the Clinical Management of Acute Cholangitis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000008618

Enrollment

200

Registered

2012-08-06

Start date

2012-08-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with cholestasis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with cholestasis due to choledocholithiasis, pancreato-biliary malignancy, and benign bile duct stricture

Exclusion criteria

Exclusion criteria: Patients with acute cholecystitis, hepatic abscess, acute pancreatitis, recurrence of cancer, liver cirrhosis, chronic kidney disease, and chronic obstructive pulmonary disease and patients receiving long term steroid treatment

Design outcomes

Primary

Measure	Time frame
1. To set up the cut-off value of serum procalcitonin level in the diagnosis of acute cholangitis 2. To set up the cut-off value of serum procalcitonin level in the severitiy assessment of acute cholangitis	—

Countries

Japan

Contacts

Public ContactFumihiko Miura

Teikyo University School of Medicine Department of Surgery

Outcome results